Literature DB >> 27603721

Allogeneic Sensitization and Tolerance Induction After Corneal Endothelial Cell Transplantation in Mice.

Jun Yamada1, Morio Ueno2, Munetoyo Toda2, Katsuhiko Shinomiya2, Chie Sotozono2, Shigeru Kinoshita3, Junji Hamuro2.   

Abstract

PURPOSE: We evaluated the allogeneic response after corneal endothelial cell transplantation in the anterior chamber (AC) in a new mouse model by examining the acquisition of a delayed-type hypersensitivity (DTH) response, induction of allogeneic AC-associated immune deviation (ACAID), and acquisition of delayed transplantation tolerance.
METHOD: The corneal eyecups from C57BL/6 mice were prepared. The epithelial layer was detached with EDTA solution and treated with trypsin to release mouse-derived primary corneal endothelial cells (mpCECs). The mpCECs (1 × 104 cells) were transplanted into the AC of the eye or subcutaneously (SC) into the neck of BALB/c mice. In the mouse model of endothelial cell transplantation, the endothelial cells in a 2-mm central area of the cornea were eliminated by cryoinjury. The mpCEC transplant model was evaluated by measuring allogeneic cell survival and corneal thickness. The allospecific DTH response and ACAID induction were evaluated 1 week after transplantation. The long-term transplantation tolerance was evaluated by observing a secondary penetrating keratoplasty (PKP) performed on the same donor C57BL/6 mice.
RESULTS: The SC injection of mpCECs induced a DTH response, whereas the AC injection induced ACAID. However, eyes inflamed by cryoinjury showed neither the DTH response nor ACAID following AC injection. The mpCECs survived for at least 1 week after injection. Penetrating keratoplasty allografts at 8 weeks after mpCEC transplantation survived indefinitely (100%).
CONCLUSIONS: The mpCECs display low allogenicity in the AC and are capable of inducing allogeneic tolerance. Corneal endothelial cell transplantation into the AC may represent a safe technique for allogeneic transplantation.

Entities:  

Mesh:

Year:  2016        PMID: 27603721     DOI: 10.1167/iovs.15-19020

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  Animal models of corneal endothelial dysfunction to facilitate development of novel therapies.

Authors:  Sangwan Park; Brian C Leonard; Vijay Krishna Raghunathan; Soohyun Kim; Jennifer Y Li; Mark J Mannis; Christopher J Murphy; Sara M Thomasy
Journal:  Ann Transl Med       Date:  2021-08

2.  Long-term observation after transplantation of cultured human corneal endothelial cells for corneal endothelial dysfunction.

Authors:  Peng Sun; Lin Shen; Yuan-Bin Li; Li-Qun Du; Xin-Yi Wu
Journal:  Stem Cell Res Ther       Date:  2022-06-03       Impact factor: 8.079

3.  Conversion of mouse embryonic fibroblasts into neural crest cells and functional corneal endothelia by defined small molecules.

Authors:  Shao-Hui Pan; Ning Zhao; Xiang Feng; Ying Jie; Zi-Bing Jin
Journal:  Sci Adv       Date:  2021-06-04       Impact factor: 14.136

4.  Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses.

Authors:  Julie Vendomèle; Safa Dehmani; Quentin Khebizi; Anne Galy; Sylvain Fisson
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

5.  Long-Term Observation and Sequencing Analysis of SKPs-Derived Corneal Endothelial Cell-Like Cells for Treating Corneal Endothelial Dysfunction.

Authors:  Lin Shen; Peng Sun; Liqun Du; Jing Zhu; Chengqun Ju; Hui Guo; Xinyi Wu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.